Welcome to our dedicated page for Conmed news (Ticker: CNMD), a resource for investors and traders seeking the latest updates and insights on Conmed stock.
CONMED Corporation (NYSE: CNMD) is a medical equipment company in the surgical and medical instrument manufacturing industry. Its products are used in sports medicine procedures and general surgeries across specialties such as orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. The CONMED news feed on this page aggregates company-issued press releases and other coverage related to its operations, strategy and financial performance.
Recent news highlights include updates on portfolio optimization, such as CONMED’s announced intent to exit its gastroenterology product lines and to conclude a distribution agreement for a biliary stent product. The company has linked this decision to a focus on core markets in minimally invasive, robotic and laparoscopic surgery, smoke evacuation, and orthopedic soft tissue repair. News items also cover quarterly and year-to-date financial results, where CONMED reports net sales by orthopedic and general surgery categories, and by single-use and capital products, along with domestic and international growth metrics.
Investors and observers can also follow governance and leadership developments through this news stream. CONMED has issued releases about changes to its Board of Directors, including the appointment of a new independent director and the resignation of another director to take a leadership role at another organization. The company has also announced a planned transition of its Chief Financial Officer, describing the timing and advisory period associated with that change.
Other news topics include capital allocation decisions, such as the declaration of a quarterly cash dividend and the subsequent authorization of a share repurchase program with suspension of the dividend, as well as participation in healthcare investment conferences where CONMED presents investor materials and financial guidance. Users interested in CNMD can use this page to review these types of announcements over time and to see how the company describes its strategy, operations and financial outlook.
CONMED Corporation (NYSE: CNMD) has announced its Annual Meeting of Stockholders, to be held virtually on May 19, 2021, at 1:30 p.m. ET. Shareholders of record by March 29, 2021, are eligible to vote. CONMED specializes in medical technology, particularly surgical devices for minimally invasive procedures across various specialties. The company cautions that forward-looking statements may be affected by uncertainties, including the impact of COVID-19 on surgical volumes and supply chains, among other risk factors.
CONMED Corporation (NYSE: CNMD) announced participation in a virtual fireside chat at the KeyBanc Life Sciences & MedTech Investor Forum on March 23, 2021, at 11:30 a.m. ET. The session will feature Chair and CEO Curt R. Hartman and CFO Todd W. Garner. Investors can access the live webcast via the Company’s website at www.conmed.com, which will be available for replay post-event. CONMED specializes in minimally invasive surgical devices used across various medical specialties.
CONMED Corporation (NYSE: CNMD) has announced a quarterly cash dividend of $0.20 per share, payable on April 5, 2021 to shareholders on record as of March 15, 2021.
CONMED is a medical technology company that provides surgical devices for minimally invasive procedures, serving various specialties including orthopedics and neurosurgery. The announcement reflects the company's ongoing commitment to returning value to shareholders.
CONMED Corporation (NYSE: CNMD) announced participation of Curt R. Hartman, Chair of the Board and CEO, alongside Todd W. Garner, CFO, in a virtual fireside chat at the 10th Annual SVB Leerink Global Healthcare Conference. The event is scheduled for 9:20 a.m. ET on February 25, 2021.
The live webcast will be available in the ‘Investors’ section of their website, and a replay will be accessible post-event. CONMED is a provider of surgical devices for minimally invasive procedures across various specialties, including orthopedics and neurosurgery.
CONMED Corporation (NYSE: CNMD) reported Q4 2020 sales of $252.8 million, down 4.5% year-over-year, with domestic revenue decreasing 0.7% and international revenue falling 9.1%. Diluted EPS rose to $0.81 from $0.49 in Q4 2019, while adjusted EPS decreased from $0.90 to $0.84. For the full year, sales were $862.5 million, a 9.7% decline, and diluted EPS was $0.32 versus $0.97 in 2019. The company expects 2021 revenue between $975 million and $1.02 billion, with adjusted EPS forecasted at $2.85 to $3.05.
CONMED Corporation (CNMD) will report its fourth quarter and full year 2020 financial results on January 27, 2021, post-market close. A conference call hosted by management will take place at 4:30 p.m. ET to discuss these results. Participants can join the call by dialing specific numbers provided or via a webcast accessible through the company’s website. A recording of the call will be available for one week following the event. The company specializes in surgical devices for minimally invasive procedures across various medical specialties.
CONMED Corporation (NYSE: CNMD) announces that Curt R. Hartman and Todd W. Garner will present at the 39th Annual J.P. Morgan Virtual Healthcare Conference on January 11, 2021, at 10:00 a.m. ET. The presentation will be accessible via a live webcast on the Company's website at www.conmed.com, with a replay available post-event. CONMED specializes in medical technology, providing surgical devices for minimally invasive procedures across various specialties, including orthopedics and neurosurgery.
CONMED Corporation (NYSE: CNMD) announced participation in the Piper Sandler 32nd Annual Virtual Healthcare Conference. CEO Curt R. Hartman and CFO Todd W. Garner will feature in a pre-recorded fireside chat, available from 10:00 a.m. ET on November 23 until December 3, 2020. Interested parties can access the chat through the conference site or via the Company’s website. CONMED specializes in surgical devices for minimally invasive procedures across various specialties including orthopedics and neurosurgery.
CONMED Corporation (NYSE: CNMD) has declared a quarterly cash dividend of $0.20 per share, scheduled for payment on January 5, 2021, to shareholders of record as of December 15, 2020. This dividend reflects the company's commitment to returning value to its shareholders. As a medical technology company, CONMED offers surgical devices for various medical specialties including orthopedics, general surgery, and more. The announcement signals confidence in the company's ongoing financial health and operational stability.
CONMED Corporation (NYSE: CNMD) announced a change in its presentation time at the Jefferies Virtual London Healthcare Conference to 11:25 a.m. ET on November 18, 2020. Todd W. Garner, Executive Vice President and CFO, will represent the company. The presentation will be available via a live webcast on the company's website, with a replay accessible afterward.
CONMED specializes in medical technology, providing surgical devices for minimally invasive procedures across various specialties, including orthopedics, general surgery, and more. For further details, visit www.conmed.com.